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Abstract
Methionine (Met) is an essential amino acid that is needed for the synthesis of S-adenosylmethionine (AdoMet), the major
biological methylating agent. Methionine used for AdoMet synthesis can be replenished via remethylation of homocysteine.
Alternatively, homocysteine can be converted to cysteine via the transsulfuration pathway. Aberrations in methionine
metabolism are associated with a number of complex diseases, including cancer, anemia, and neurodegenerative diseases.
The concentration of methionine in blood and in organs is tightly regulated. Liver plays a key role in buffering blood
methionine levels, and an interesting feature of its metabolism is that parallel tracks exist for the synthesis and utilization of
AdoMet. To elucidate the molecular mechanism that controls metabolic fluxes in liver methionine metabolism, we have
studied the dependencies of AdoMet concentration and methionine consumption rate on methionine concentration in
native murine hepatocytes at physiologically relevant concentrations (40–400 mM). We find that both [AdoMet] and
methionine consumption rates do not change gradually with an increase in [Met] but rise sharply (,10-fold) in the narrow
Met interval from 50 to 100 mM. Analysis of our experimental data using a mathematical model reveals that the sharp
increase in [AdoMet] and the methionine consumption rate observed within the trigger zone are associated with metabolic
switching from methionine conservation to disposal, regulated allosterically by switching between parallel pathways. This
regulatory switch is triggered by [Met] and provides a mechanism for stabilization of methionine levels in blood over wide
variations in dietary methionine intake.
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Introduction
Methionine, an essential amino acid, plays a significant role in
intracellular one-carbon and sulfur metabolism consequently
linking antioxidant and methylation homeostasis (Figure 1). Since
methionine is involved in many intracellular processes its levels in
blood and in different organs need to be tightly regulated. In fact,
methionine levels in blood and liver do not change over a several-
fold variation in dietary methionine intake [1–3]. Aberrations in
methionine, and therefore in methylation and antioxidant
metabolism, are associated with a number of complex diseases,
including cancer, anemia, neurodegenerative diseases, and
developmental abnormalities [4,5]. Hence, elucidating the multi-
ple switches that regulate methionine metabolism is key to
understanding their dysregulation. Such information may also
permit intervention that would reverse disease states.
Liver is considered to be the main organ that removes excess
methionine from the organism and regulates the methionine level
in blood. The metabolism of methionine in liver is more complex
than in other organs; it is characterized by a unique, liver-specific
enzyme profile (Figure 1), which includes the methionine
adenosyltransferase I (MATI) and methionine adenosyltransferase
III (MATIII) isoforms of methionine adenosyltransferase. Methi-
onine adenosyltransferase II (MATII) is present only in extrahe-
patic tissues. The enzymatic reaction of the MATIII isoform
exhibits a rate dependence on AdoMet concentration that is the
converse of MATI and MATII. Thus, while MATI, like MATII, is
inhibited by AdoMet, MATIII is activated at high concentrations
of AdoMet [6,7]. Liver also possesses glycine-N-methyltransferase
(GNMT), betaine homocysteine S-methyltransferase (BHMT),
and cystathionine b-synthase (CBS) at levels that are much higher
than those found in other organs and tissues [8]. Thus, an
interesting feature of liver methionine metabolism is that there are
parallel tracks for the synthesis and utilization of AdoMet, and at
the homocysteine junction, methionine can either be recycled or
committed to the synthesis of cysteine, which can then be either
utilized biosynthetically or catabolized (Figure 1).
Despite the large number of studies on methionine metabolism
in liver [8] its regulation as well as the kinetics of the methionine
disposal, are not well understood. Furthermore, the dependence
of liver methionine metabolism on fluctuating methionine
concentration ([Met]) within a physiologically relevant range
has not been investigated. To elucidate the molecular mechanism
that controls metabolic fluxes via parallel tracks in liver
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ical model [9], which revealed the possibility of a threshold
dependence of liver methionine metabolism on [Met]. This
simple qualitative model predicted the existence of two modes in
liver methionine metabolism characterized by low metabolic rates
and metabolite levels at methionine concentrations equal to or
below its normal physiological value and by high metabolic rates
and metabolite concentrations at methionine concentrations
above its physiological value. The model predicted that under a
specific set of conditions, methionine metabolism switches sharply
from one mode to another when [Met] slightly exceeds its
physiological value. The switch from the ‘‘low’’ to ‘‘high’’ mode is
associated with a sharp increase in steady-state AdoMet
concentrations. It was presumed that this metabolic switch
enables conservation at low methionine levels and disposal at
high methionine levels, and is associated with a redistribution of
metabolic flux between remethylation and transsulfuration.
However, a detailed analysis of the metabolic switch could not
be undertaken with the simple model because it did not include
descriptions of remethylation and transsulfuration fluxes in an
explicit form. Moreover, the simple model had significant
limitations such as the loss of stability at methionine concentra-
tions exceeding the normal physiological value by ,10% and
unrealistically slow kinetics for transitional processes [9], raising
questions about its utility for experimental verification at the high
end of physiologically relevant methionine concentrations and on
a real time scale.
In this study, we have analyzed the experimental dependencies
of [AdoMet] and methionine consumption rate on [Met] in
native murine hepatocytes within a physiologically relevant
concentration range (40 to 400 mM). We have found that both
[AdoMet] and methionine consumption rate do not respond
gradually with increasing [Met] but rise sharply, increasing ,10-
fold within the narrow [Met] concentration interval from 50 to
100 mM in accordance with the predictions of our preliminary
mathematical modeling of this pathway [9]. We used our
experimental results for construction and quantitative verification
of the extended mathematical model of liver methionine
metabolism, which included a detailed description of the kinetics
of all the relevant enzymes, a simplified description of folate
metabolism and a new rate equation for the MATIII reaction.
The new rate equation for the MATIII reaction was developed to
describe the experimental data at methionine concentrations
above its normal physiological value. Analysis of the model
reveals that the sharp increase in [AdoMet] and methionine
consumption rate observed in hepatocytes at increasing [Met] are
associated with a sharp transition in methionine metabolism from
a conservation to a disposal mode (i.e. from remethylation to
transsulfuration). The transition is controlled by allosteric
regulation of enzymes that results in switching metabolic flux
between parallel pathways for AdoMet synthesis and utilization.
This metabolic switch is triggered by methionine and provides a
mechanism for stabilization of methionine levels in blood over
wide variations in dietary methionine intake.
Our study reveals an excellent correspondence between the
experimental and predicted behavior of liver cells in response to
variations in [Met] and demonstrates the existence of a novel
allosteric mechanism for switching metabolic fluxes between
parallel pathways.
Figure 1. Scheme for liver methionine metabolism. The solid
arrows show enzymatic reactions. Dashed arrows indicate the allosteric
regulatory influence of metabolites to enzymes. Red and blue colors
indicate activation and inhibition respectively. Besides its role in protein
synthesis, methionine is a substrate for the synthesis of S-adenosylme-
thionine (AdoMet), which is a ubiquitous methyl donor for numerous
methyltransferases and is a precursor for polyamine synthesis. A
product of the methyltransferase reactions is S-adenosylhomocysteine
(AdoHcy), which in turn, is cleaved to adenosine and homocysteine in a
reaction catalyzed by S-adenosylhomocysteinase (AHC). Homocysteine
can be remethylated to methionine using the methyl group of methyl
tetrahydrofolate (MTHF), or betaine, in reactions catalyzed by methio-
nine synthase (MS) and betaine homocysteine methyltransferase
(BHMT), respectively. In many tissues, homocysteine is also metabolized
via the transsulfuration pathway to generate cysteine, the limiting
substrate for synthesis of glutathione (GSH), a major intracellular
antioxidant. Enzyme abbreviations: AHC: adenosylhomocysteinase;
BHMT: betaine homocysteine S-methyltransferase; CBS: cystathionine
b-synthase; GNMT: glycine-N-methyltransferase; MATI, III: methionine
adenosyltransferase I, III; MS: methionine synthase; MTHFR: methylene-
tetrahydrofolate reductase. Metabolite abbreviations: AdoHcy: S-ade-
nosylhomocysteine; AdoMet: S-adenosylmethionine; Hcy: homocyste-
ine; MGA: methyl group acceptor; MTHF: 5-methyltetrahydrofolate;
GSH: glutathione.
doi:10.1371/journal.pcbi.1000076.g001
Author Summary
Methionine is an essential amino acid that is highly toxic at
elevated levels, and the liver is primarily responsible for
buffering its concentration in circulation. Intracellularly,
methionine is needed for the synthesis of S-adenosylme-
thionine (AdoMet), the major biological methylating agent.
Methionine used for AdoMet synthesis can be replenished
via remethylation of homocysteine. Alternatively, homo-
cysteine can be converted to cysteine via the transsulfura-
tion pathway. A specific feature of liver methionine
metabolism is the existence of twin pathways for AdoMet
synthesis and degradation. In this study, we analyzed the
dependence of methionine metabolism on methionine
concentration in liver cells using a combined experimental
and theoretical approach. We find a sharp transition in rat
hepatocyte metabolism from methionine conservation to
a disposal mode with an increase in methionine concen-
tration above its physiological range. Mathematical mod-
eling reveals that this transition is afforded by an allosteric
mechanism for switching between parallel metabolic
pathways. This study demonstrates a novel mechanism
of trigger behavior in biological systems by which the
substrate for the metabolic network switches metabolic
flux between parallel tracks for sustaining two different
metabolic modes.
Switch in Mammalian Sulfur Metabolism
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Effect of Initial Concentration of Methionine on the
Intracellular Concentrations of AdoMet, AdoHcy, and
Methionine Consumption Rate in Murine Hepatocytes
In a suspension of murine hepatocytes incubated with 40 mM
methionine, the intracellular concentration of AdoMet was quite
stable over 3 h. The average value of [AdoMet] obtained under
these conditions in 24 independent experiments was
79637 mmol/l cells (mean6SD). At higher methionine concen-
trations, the intracellular [AdoMet] increased within 20–30 min
and then reached a plateau within ,1 h, representing a new
steady-state level, which did not change further during the
following 1–2 h (Figure 2A). As the initial [Met] in the suspension
was increased, the steady-state AdoMet level increased monoton-
ically. However, the major increase in [AdoMet] was observed at
an initial [Met] above 200 mM. When the initial [Met] was 200–
240 mM or 400 mM, the intracellular AdoMet level reached values
of 5906180 (n=9) and 9306350 mmol/l cells (n=12) respective-
ly, exceeding the concentration obtained at 40 mM methionine by
11- to 15-fold, on average.
Under control conditions, i.e., at 40 mM methionine, the
average intracellular concentration of S-adenosylhomocysteine
(AdoHcy), obtained in 7 independent experiments was
7.167.0 mmol/l cells. The concentration of AdoHcy also in-
creased with the increase in initial [Met] in the cell suspension,
reaching a value of 76621 mmol/l cells at an initial [Met] of
400 mM. This exceeded the concentration obtained at 40 mM
methionine, on average, by 10-fold (not shown).
The concentration of methionine in the incubation medium
decreased with time, due to methionine consumption by
hepatocytes (Figure 2B). The dependence of [Met] on time was
approximated by linear kinetics, and the slope of the correspond-
ing line normalized to cell volume was taken as the rate of
methionine consumption by hepatocytes. The rate of methionine
consumption increased with an increase in the initial [Met]. At
40 mM methionine, the average rate of methionine consumption,
obtained in 15 independent experiments, was 0.8660.40 mmol/
h?l cells. The rate of methionine consumption by hepatocytes
increased to 6.062.4 mmol/h?l cells at an initial [Met] of 400 mM
(n=12), exceeding its value at 40 mM methionine by 8.163.6-
fold. Our mathematical model, which is described in the Methods
section and in Supporting Text S1 and S2, provides a satisfactory
description of the [AdoMet] and [Met] kinetics observed
experimentally in hepatocytes in response to changes in [Met]
(Figure 2C, D).
Dependence of Steady-State AdoMet and AdoHcy
Concentrations in Murine Hepatocytes on Methionine
Concentration
To assess the experimental dependence of steady-state AdoMet
concentration on methionine, we plotted the average intracellular
[AdoMet] measured between 60 and 160 min of incubation versus
the average [Met] measured during the same time interval. The
AdoMet concentration obtained in each experiment was normal-
ized to the maximum AdoMet levels obtained at an initial [Met] of
400 mM with the same batch of cells. Data from 12 independent
experiments are presented in Figure 3A. As can be seen, a
distinctive feature of the dependence of [AdoMet] on [Met] in
mouse hepatocytes is the sharp increase in [AdoMet] within a
narrow range of [Met] between 50 and 100 mM. Below and above
this trigger zone, the steady-state [AdoMet] increases only slightly
with an increase in [Met]. The relatively low slope of the
experimentally observed dependence of [AdoMet] on [Met] at low
methionine concentrations (Figure 3A, inset) is incompatible with a
simple hyperbolic dependence.
The quantitative mathematical model developed in the present
work exhibits a sharp increase in [AdoMet] within a narrow
concentration range of methionine above its physiological level
(Figure 3A), in good agreement with the experimental results. We
have similarly examined the dependence of steady-state AdoHcy
concentration on methionine (Figure 4). This dependence is
similar to the dependence of [AdoMet] on [Met] (Figure 3A) and is
well described by the model (Figure 4).
Dependence of the Methionine Consumption Rate on
Methionine Concentration in Murine Hepatocytes
The experimentally derived rate for methionine consumption in
hepatocytes was plotted versus the average [Met] measured
between 60 and 160 min, as described above for AdoMet
(Figure 3B). The values obtained for the methionine consumption
rate in each experiment were normalized to the rate obtained with
the same batch of cells at an initial [Met] of 400 mM. As seen for
the behavior of the intracellular AdoMet concentration, the
methionine consumption rate increased several-fold in a relatively
narrow concentration interval of methionine and then did not
change so significantly. The experimental data are in good
agreement with the prediction of the mathematical model
(Figure 3B). The relatively low slope at low [Met] is inconsistent
with the methionine consumption rate being a simple hyperbolic
function of [Met] (Figure 3B, inset).
Metabolic Switch Between Transmethylation and
Transsulfuration (Methionine Conservation and Disposal)
The extended model supports analysis of specific reaction rates
and metabolites in the sharp transition between low and high
[AdoMet] and methionine consumption rate within a narrow
[Met] range. The model reveals that at physiological [Met]
(,50 mM), almost all the AdoMet is produced by the MATI
isoform and consumed by cellular methylases, thereby meeting the
demands for methylation reactions (Figure 5A). Under these
conditions, the futile metabolic flux through GNMT is very low
because [AdoMet] is low and high levels of 5-methyltetrahydro-
Figure 2. Kinetics of [AdoMet] and [Met] in a suspension of
murine hepatocytes incubated at different initial [Met]. (A,B)
Data from a representative experiment obtained at a cell density of
1?10
6 cells/ml and initial [Met] of %-40, n-120, #-240, and ,-
400 mmol/l respectively. (C,D) Model simulation, calculated using a
complete system of equations (Text S1 and Equation S1) at wmed/
whep=99 (1% cell suspension) and V
influx=0. Initially, all model variables
except [Met] were set to the normal physiological steady-state values
(Table S3), and calculations were started at different initial [Met] values
as indicated above each line.
doi:10.1371/journal.pcbi.1000076.g002
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steady-state rate of AdoMet production (V
MATI+V
MATIII) (for
complete definition of terms, see Methods) is not equal to the
net rate of methionine consumption (V
MATI+V
MA-
TIII2V
MS2V
BHMT) because a significant amount of AdoMet is
produced due to recirculation of metabolites via methionine
synthase (MS) and betaine homocysteine S-methyltransferase
(BHMT) (Figure 5). A small increase in [Met] above its normal
value leads to a moderate increase in [AdoMet]. Due to the
opposing influence of AdoMet on MATI and MATIII isoforms
(Figure 1), the rate of MATI decreases, while the rate of MATIII
increases and the total rate of AdoMet production increases
slightly. At a threshold value for methionine (,70 mM in the
model) the rate of the MATIII reaction exceeds the rate of the
MATI reaction and the rate of AdoMet production exceeds the
total activity of cellular methylases. This leads to a rapid and auto-
accelerated accumulation of AdoMet and an increase in the rate of
the MATIII reaction due to positive feedback regulation of
MATIII by AdoMet, which cannot be compensated by a further
decrease in the MATI reaction rate. Also, increased AdoMet levels
inhibit methylenetetrahydrofolate reductase (MTHFR) that leads
to a significant decrease in [MTHF]. Consequently, GNMT is
strongly activated due to its sigmoidal dependence on [AdoMet]
and decreased inhibition by MTHF under these conditions
(Figure 1, Figure 5). The sharp activation of GNMT results in
consumption of excess AdoMet produced by activated MATIII
providing a new steady state of methionine metabolism charac-
terized by high [AdoMet] and a high metabolic rate. This
regulation provides the metabolic switch in methionine metabo-
lism from the ‘‘low’’ to the ‘‘high’’ metabolic mode. Thus, above
the threshold concentration for methionine, the rate of AdoMet
synthesis increases several-fold, due mainly to the activity of
MATIII. The contribution of MATI to total AdoMet synthesis
decreases to ,10% and excess AdoMet is metabolized via
GNMT. Below the threshold [Met], a large fraction of the
methionine used in AdoMet synthesis is regenerated via
transmethylation reactions catalyzed by MS and BHMT, and
the net rate of methionine consumption is low (Figure 5, Figure 3B,
theoretical curve). Above the threshold, the net rate of methionine
consumption increases dramatically (Figure 3B, theoretical curve),
and methionine is primarily catabolized via the transsulfuration
pathway (Figure 5B). The increased AdoMet concentration
inhibits MTHFR that leads to a sharp decrease in the MS
substrate, MTHF. This in turn, leads to a decrease in the MS
reaction rate despite the increased level of the other substrate,
homocysteine (Hcy). Meanwhile, the committing enzyme in the
transsulfuration pathway, CBS, is activated due to an increase in
the concentration of its substrate, homocysteine and its allosteric
activator, AdoMet. These results are in good agreement with the
Figure 3. The methionine concentration dependence of steady-
state values of (A) [AdoMet] and (B) the rate of methionine
consumption in mouse hepatocytes. Symbols indicate experimen-
tal data obtained in 12 independent experiments, with each symbol
representing a single experiment. Solid lines show the results of
mathematical modeling calculated using the parameter values indicat-
ed in Tables S1 and S2. Each experimental data point for [AdoMet]
shows the mean6SD of samples collected at least in triplicate in the
steady-state phase of AdoMet kinetics. Each experimental data point for
methionine consumption rate shows the result of a linear fit
(mean6SD) of methionine kinetics, obtained with samples collected
between 20 and 160 min of cell incubation. Horizontal error bars show
the methionine concentration intervals corresponding to the steady-
state AdoMet concentrations. In each experiment, values for [AdoMet]
and methionine consumption rate were normalized to values obtained
at an initial methionine concentration of 400 mM. The theoretical curves
were normalized to values obtained at 400 mM methionine. Insets in
both (A) and (B) show the experimental (symbols) and simulated (line)
data in greater detail at low [Met]. Error bars were removed for clarity.
doi:10.1371/journal.pcbi.1000076.g003
Figure 4. The dependence of steady-state AdoHcy concentra-
tion on methionine in mouse hepatocytes. Symbols indicate
experimental data obtained in 7 independent experiments. Data
obtained in the same experiment are shown by the same symbols
used in Figures 3 and 4. The solid line shows the result of mathematical
modeling calculated using the parameter values indicated in Tables S1
and S2. Each experimental data point for [AdoHcy] is represented as the
mean6SD of at least 3 samples. Horizontal error bars show methionine
concentration intervals corresponding to the steady-state AdoMet
concentrations. In each experiment, values for [AdoHcy] were
normalized to value obtained at an initial methionine concentration
of 400 mM. Similarly, theoretical data were normalized to the value
obtained at 400 mM methionine.
doi:10.1371/journal.pcbi.1000076.g004
Switch in Mammalian Sulfur Metabolism
PLoS Computational Biology | www.ploscompbiol.org 4 May 2008 | Volume 4 | Issue 5 | e1000076published experimental data demonstrating the decrease in the
fraction of methionine produced via remethylation and activation
of methionine catabolism via the transsulfuration pathway at high
[Met] in liver or hepatocytes [2,10,11].
Mechanism of Stabilization of Methionine Concentration
The metabolic switch between methionine conservation and
disposal buffers methionine levels in liver and provides a
mechanism for stabilizing liver and blood methionine concentra-
tions over a wide range of dietary methionine intake. Indeed, rapid
normalization of blood and liver methionine is observed after food
consumption [12] or methionine injection [1,13]. Blood and liver
methionine levels do not vary significantly over a several-fold
range in dietary methionine intake [1–3]. To demonstrate
methionine stabilization in the extended model, we analyzed the
dependence of steady-state methionine metabolism on the rate of
methionine influx. Figure 6A shows the computed dependence of
the steady-state [Met] on the normalized rate of methionine influx
into hepatocytes. As one can see, [Met] is stabilized over a ,6-fold
increase in the rate of methionine influx. The rate of the CBS
reaction increases proportionally with the increase in the rate of
methionine influx while the rate of transmethylation, contributed
collectively by MS and BHMT, does not change significantly
decreasing only at very high values of methionine influx
(Figure 6B). This indicates that stabilization of [Met] is provided
via catabolism by adjusting the flux through the transsulfuration
pathway.
Discussion
The methionine metabolic pathway represents a useful
paradigm for studying gene-nutrient interactions since it is richly
dependent on the input of dietary factors (viz. amino acids and B-
vitamins). Moreover, several genetic polymorphisms have been
described in the pathway’s enzymes that are correlated with risk
for various complex diseases [14–17]. An integrated understanding
of the regulation of methionine metabolism is important because
of its critical role in modulating the two major homeostatic systems
governing methylation and antioxidant metabolism, which are
often dysregulated in complex diseases. Attaining this understand-
ing is, however, a challenge because methionine metabolism is
complex; the pathway has branches and cycles in addition to
parallel fluxes at several steps of intermediate transformation.
Further, regulation of the pathway enzymes by intermediates
increases the complexity of the system. Mathematical modeling is
a powerful tool for studying the mechanisms of regulation in
complex metabolic systems and for analyzing the behavior of a
system under different natural and experimentally induced
conditions. Previously, simple mathematical models of liver
methionine metabolism have been developed and used to analyze
and predict the response of the system to changes in [Met] and
other variables [9,18,19].
The most striking prediction of our previously published simple
mathematical model describing methionine metabolism is that a
substrate (methionine) can induce the sharp transition between
two modes in liver methionine metabolism characterized by low
metabolic rates and metabolite levels at methionine concentrations
equal to or below its normal physiological value and by high
metabolic rates and metabolite concentrations at methionine
concentrations above its physiological value [9]. The model
predicted that this transition is triggered within a narrow
methionine concentration range. In addition to the limitations of
the simple model discussed in the introduction, we could not verify
or adjust the model parameters to obtain a quantitative description
of methionine metabolism because of the scant information
available on the dependence of metabolic fluxes on [Met] in liver
or in hepatocytes. Even the rate of methionine consumption under
normal physiological conditions was unknown.
To address these gaps, we experimentally determined the
responsiveness of methionine metabolism in murine hepatocytes to
Figure 5. The dependence of (A, B) steady-state reaction rates
and (C) metabolite concentrations in methionine metabolism
on [Met] as calculated by the model. The enzyme and metabolite
abbreviations are denoted by the curves corresponding to their
behavior. All parameter values used for the calculations are given in
Tables S1 and S2.
doi:10.1371/journal.pcbi.1000076.g005
Figure 6. The influence of different methionine influx rates on
the steady-state values of (A) [Met] and (B) CBS, MS, and BHMT
reaction rates calculated by the model. The influx was normalized
to a value of 0.76 mmol/h?l cells, which provides normal physiological
steady-state [Met] value of 50 mM (indicated by the circle) in the model.
All parameter values used for the calculations are given in Tables S1 and
S2.
doi:10.1371/journal.pcbi.1000076.g006
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dependence of [AdoMet] and the rate of methionine consumption
in hepatocytes on [Met] within a narrow range of extracellular
[Met] that lies just above the physiological concentration of
circulating methionine (,50 mM). These data supported the
development of an extended quantitative model of liver methio-
nine metabolism, which also includes rate equations for MS,
BHMT and CBS, and a simplified treatment of folate metabolism.
Importantly, without the link between methionine and folate
metabolism the extended model failed to provide a realistic
description of the GNMT reaction rate, confirming the experi-
mentally established regulation of GNMT by the folate derivative,
MTHF. Enzymatic reaction rates were described using mecha-
nism-based equations and the kinetics parameters were adjusted
from ranges reported in the literature and our own experimental
data. In addition, a new equation had to be developed to describe
the MATIII reaction, including both activation and inhibition of
the enzyme at high [AdoMet], in order to describe the
experimental data at [Met] above its normal physiological value.
A significant attribute of the extended model is that it provides a
good quantitative description of our experimental results,
including steady-state values and transitional processes over a
wide range of [Met].
The extended model was used to analyze two types of
experiments. To assess the response of hepatocytes ex vivo, to
the parameter, i.e., varying [Met], the behavior of pathway
metabolites and reaction rates were analyzed. To describe in vivo
conditions, [Met] was considered as a model variable and the rate
of methionine intake was considered as an independent parameter.
A good agreement was observed between the simulated and
observed ex vivo experimental data. Our experimental results
demonstrate that a sharp increase in [AdoMet] in hepatocytes is
accompanied by a several-fold increase in the methionine
consumption rate (Figure 3). This behavior is reversible and liver
metabolism switches back to a conservation mode when the [Met]
decreases below the threshold level. Our analysis of the in vivo
response to varying intake of methionine reveals that the metabolic
switch between methionine conservation and disposal provides a
mechanism for stabilizing liver and blood methionine concentra-
tions over a wide range of dietary methionine intake. This
mechanism is associated with the regulation of the CBS reaction
rate (Figure 6) in addition to regulation by MATI/III and GNMT.
Homeostasis requires that the steady-state transsulfuration flux
must be equal to or less than the net rate of methionine
consumption. The normal rate of methionine consumption
observed in murine hepatocytes, was ,1 mmol/h?l cells, which
represents ,1.3% of murine liver CBS activity under maximal
velocity conditions [20]. In the model, under physiological
conditions, the rate of the CBS reaction is ,0.6% of CBS activity
(Figure 5B and Table S1). Thus, our experimental and theoretical
data reveal that under normal physiological conditions, liver CBS
works at a very small fraction of its maximal capacity, and that it
can be activated several fold at high [Met] to increase the volume
of sulfur flowing through the transsulfuration pathway.
Thus, liver methionine metabolism exhibits trigger behavior
that results from allosterically regulated switching between two sets
of enzymes that catalyze parallel metabolic fluxes. In the
methionine conservation mode, the metabolic flux is determined
by one set of enzymes, which includes MATI and functional
methylases, while in the methionine disposal mode, the metabolic
flux is determined by a second set of enzymes that includes
MATIII and GNMT (Figure 7). To our knowledge, such a
mechanism of trigger behavior that causes metabolic flux to switch
between parallel pathways has not been reported previously in
other metabolic systems.
A sharp transition from one steady state to another in the
background of a monotonic change in one parameter (or stimulus)
is observed in many biological processes including ontogenesis, cell
cycle and signal transduction. An ideal mechanism for trigger
behavior is provided in a system that exhibits bistability, i.e., when
an area of instability separates two stable steady states. In this case,
the system can jump from one steady-state to the other, and stable
intermediate states do not exist in the pathway. There are a
number of theoretical and experimental reports of bistability in
different biological processes [21–25]. In fact, within a fairly wide
range of parameters, both the simple and extended models predict
the existence of bistability in the system, leading to the trigger
behavior in metabolite concentrations and metabolic fluxes,
including [AdoMet] that jumps from its physiological concentra-
tion to significantly higher levels when the [Met] crosses a
threshold value. This bistability results in a hypersensitivity of
methionine metabolism to changes in methionine levels within a
narrow concentration interval. The theoretical mechanism of
bistability, which can be realized in liver methionine metabolism,
is described in Text S3 and Figures S3, S4, and S5.
However, bistability is not absolutely essential for effective
regulation of liver methionine metabolism. Our model shows that
even sharp monotonic dependence of methionine metabolism on
Figure 7. Scheme showing switching between parallel metabolic tracks triggered by the concentration of methionine. The width of
the solid arrows is qualitatively proportional to the metabolic flux through each step. MT refers to functional methylases (methyltransferases). The
dashed arrows indicate the influence of substrate and allosteric regulation, which determine flux in the ‘‘low’’ and ‘‘high’’ metabolic modes. The red
and blue colors indicate activation and inhibition, respectively.
doi:10.1371/journal.pcbi.1000076.g007
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switching between methionine conservation and disposal modes,
providing a mechanism for effective stabilization of methionine
levels. The results demonstrate that both [AdoMet] and the rate of
methionine consumption in hepatocytes increase slowly with an
increase in methionine level at low [Met] (0–50 mM) and then
increase sharply in a narrow concentration range of 50–100 mM
(Figure 3) in accordance with model predictions. While the
experimental data cannot distinguish between a jump versus a
monotonic increase in [AdoMet] and the rate of methionine
consumption with an increase in [Met] they are not well described
by a simple hyperbolic behavior (Figure 8). Formal approxima-
tions of the initial part of our experimental points at [Met] from 0
to 100 mM with the simple power function: Y=A+B*X
n, provide
the best fit at n=2.30 for AdoMet and at n=1.43 for methionine
consumption rate. This is consistent with a sharp, non hyperbolic
increase in [AdoMet] and methionine consumption rate in a
narrow interval of [Met], confirming our model predictions.
Similar power function approximation of regular Michaelis-
Menten hyperbola Y=X/(100+X) gives n=0.64.
The sharp change in methionine metabolism observed in
hepatocytes at increasing methionine concentration is in striking
contrast to the relatively weak dependence we have previously
observed in hepatoma cells [18]. A notable difference between
primary versus transformed hepatocytes is that the latter express
the MATII isoenzyme instead of MATI/MATIII; they also lack
GNMT [26–28]. Thus, our theoretical and experimental results
demonstrate that the presence of the MATI/MATIII and GNMT
is crucial for normal regulation of liver methionine metabolism
and for achieving a normal balance between methionine
conservation and disposal, thereby buffering methionine levels.
We note that our mathematical model describing methionine
metabolism is still relatively simple. For instance, it does not
include factors that can potentially affect liver and blood
methionine levels, such as the modulation of enzyme levels by
dietary factors [8] and methionine turnover in organs other than
liver. Nevertheless, the predictive power of the model in revealing
an unexpected mode of substrate-triggered regulation is validated
by the results reported in this study, affirming the utility of a
combined theoretical and experimental approach for the study of
metabolic regulation.
Materials and Methods
Mathematical Model
Our mathematical model is a system of ordinary differential
equations that describe the kinetics of extracellular and intracel-
lular concentrations of methionine as well as intracellular
concentrations of other intermediates of methionine metabolism
(Figure 1).
d Met ½  ext
dt
~ Vinflux{Vtranswhep
 
wmed
d Met ½ 
dt
~VtranszVBHMTzVMS{VMATI{VMATIII{Vprot
d AdoMet ½ 
dt
~VMATIzVMATIII{VMeth{VGNMT
d AdoHcy ½ 
dt
~VMethzVGNMT{VAHC
d Hcy ½ 
dt
~VAHC{VCBS{VBHMT{VMS
ð1Þ
Here [Met]ext and [Met] are the extracellular and intracellular
methionine concentrations, V
influx is the rate of methionine influx
into the system, V
trans is the rate of methionine transport into
hepatocytes, whep and wmed are total volumes of hepatocytes and
external medium, respectively, V
prot is the net rate of methionine
consumption in protein turnover, V
MATI, V
MATIII, V
GNMT, V
Meth,
V
AHC, V
CBS, V
MS, V
BHMT are the rates of reactions, catalyzed by
MATI, MATIII, GNMT, functional methylases, adenosylhomo-
cysteinase (AHC), CBS, MS, and BHMT respectively.
The reversible AHC-catalyzed reaction is assumed to be at
equilibrium because the activity of AHC is much higher than the
activity of other enzymes in the metabolic system (see Table S1).
The rate of methionine consumption in protein turnover and the
total rate of functional methylases are described by simplified
equations. Equations for rates of other enzymatic reactions are
based on known kinetics mechanisms for the respective enzymes.
We developed a new equation for the MATIII reaction in order to
describe the experimental data at [Met] above its normal
physiological value. All equations for the enzymatic reaction rates
are presented in Text S1. The development of the equation for
MATIII is described in Text S2 and Figures S1 and S2.
We do not take into account AdoMet consumption for
polyamine synthesis because its rate is about 1% of flux in
methionine metabolism [29] in normal liver.
Figure 8. Comparison between model-based and Michaelis-
Menten hyperbolic (Y=X/(X+Km) fits to the experimental data.
The data points and fits in black are the same as shown in Figure 3. The
red curves show the hyperbolic best fit using values for Km of 163 mM
(A), and 96 mM (B). The other curves show hyperbolic traces calculated
at Km values of 400 mM (blue), 50 mM (green), and 10 mM (orange). For
each curve the value obtained at 400 mM [Met] was taken as 1.0.
doi:10.1371/journal.pcbi.1000076.g008
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incubation medium can be evaluated using the following published
data[30–33].Itwasshownusingradioactivemethioninedistribution
that methionine transport in hepatocytes is fast, passive, reversible
and that the equilibrium between intracellular and extracellular
methionine is established within a few minutes (Figures 3–5 in [33]).
Moreover, these data demonstrate a linear fit between intracellular
and extracellular methionine concentrations in the range from
18 mM to 10 mM (Figure 5 in [33]). In hepatocytes, methionine is
transported via a Na
+-dependent and a Na
+-independent transport-
er, with the latter accounting for ,90% of the transport at normal
methionine concentrations, and the activity of transport is high
enough to provide equilibration of extracellular and intracellular
methionine within a few minutes (Table 2 in [32]), which confirms
the data published in [33]. The kinetics of methionine transport in
hepatocytes shows that at physiologically relevant concentration of
methionine (100 mM) and at 37uC the equilibrium is achieved in
1 min (Figure 3 in [30]). The distribution of methionine between
hepatocytes and the medium can be estimated using the data
presented in Figure 3 of [30] as follows: at 100 mM [Met] in the
medium, the equilibrium [Met] inside hepatocytes was 600 pmol/
10
6 cells. Based on the size of hepatocytes (see below in Metabolite
Analysis), 10
6 cells are estimated to have a total volume of 10 ml.
This yields an intracellular [Met] of 60 mmol/l cells. Recalculating
per volume of intracellular water, the intracellular [Met] is estimated
to be ,80 mM yielding a ratio between intra- and extra-cellular
[Met] of 0.8. Similar calculations for the data presented in Figure 5
of [33] reveal that the amino acid remains equally distributed
between the extracellular medium and inside cells at methionine
concentrations ranging from 18 mM to 10 mM. It has also been
shown in vivo that [Met] in blood plasma and in normal liver are
fairlysimilar(Table 2 in[31]).Additionally,we notethat preliminary
experiments based on direct methionine measurements confirm fast
and uniform distribution ofmethionine between hepatocytes and the
incubation medium in concentration range from 40 to 400 mM. So
we assume that extracellular and intracellular methionine concen-
trations are equal.
To incorporate the kinetics of folate metabolites into the model,
specifically 5,10-methylenetetrahydrofolate (5,10-CH2-THF) and
MTHF, which regulate MS, GNMT, and MTHFR activities, we
take into account that most folate derivatives are interconnected
via highly active and reversible enzymatic reactions [34,35]. This
allows us to consider a general folate pool with equilibrium ratios
between its components for all folates except dihydrofolate (DHF)
and MTHF. The last two metabolites are produced from 5,10-
CH2-THF in irreversible reactions with low activity [36,37].
Because of the equilibrium between components of folate pool we
assume that concentration of 5,10-CH2-THF always constitutes
20% of the total pool as seen under normal physiological
conditions [38,39]. The total intracellular concentration of all
folates is assumed to be constant, and DHF is not taken into
account because we assume that its concentration is constant.
Texts S1, S2, and S3 and Tables S1, S2, and S3 contain a detailed
description of the model and its analysis.
Hepatocyte Preparation
The experimental protocol was approved by the Scientific
Council of the National Research Center for Hematology
(NRCH). Female CBF1 mice (20–22 g) were obtained from the
laboratory animal nursery in Stolbovaya, Moscow region, Russia.
They were housed in a vivarium at the NRCH and provided with
food and water ad libitum. Hepatocytes were isolated under sodium
thiopental narcosis (i.p. injection of 5 mg/mouse). Liver was
perfused for 5–10 min through the vena porta with a solution
containing 115 mM NaCl, 5 mM KCl, 1 mM KH2PO4, 0.5 mM
EGTA, 10 mM glucose, and 25 mM HEPES buffer, pH 7.5,
saturated with 95% O2 and 5% CO2 at 37uC, followed by 7–
8 min perfusion with the same solution lacking EGTA and
containing 2.5 mM CaCl2 and 20–30 mg/ml of a collagenase-
protease mixture (Liberase Blendzyme 3, Roche). The rate of
perfusion was 7 ml/min. Then, the liver was dispersed at room
temperature in the initial perfusing solution lacking EGTA.
Hepatocytes were filtered through a 50 mm nylon mesh,
sedimented by centrifugation and washed 3 times in 45 ml
dispersing solution supplemented with 1 mM CaCl2,1 m M
MgCl2,4 0 mM methionine and 2% BSA. Cell concentration
and viability were determined using a hemocytometer after
staining with 0.4% trypan blue. Cell preparations with viability
$85% were used in all experiments. Hepatocytes were resus-
pended in the washing solution to a concentration of 1?10
6 viable
cells/ml, then 5 ml suspension aliquots were placed in 50 ml
Ehrlenmeyer flasks and agitated at the rate of 100 RPM under an
atmosphere of humidified 95% O2 and 5% CO2 at 37uC. At the
beginning of the incubation, methionine was added to flasks to a
final concentration of 40–400 mM. Cells prepared from one
animal were incubated simultaneously in several flasks at different
initial methionine concentrations for ,3 h for a single experiment.
Typically, the initial methionine concentrations were 40 mM,
400 mM, and two intermediate values.
Metabolite Analysis
At the desired time intervals aliquots of cell suspension were
collected from flasks and mixed with 0.2 volumes of 30%
trichloroacetic acid. After centrifugation the supernatant was used
for analysis of AdoMet, AdoHcy and methionine [18,30].
The concentration of AdoMet and AdoHcy were measured by
HPLC using an 8 mm Chromasil-100 C18 column, 25064.6 mm,
(Elsico, Russia) under isocratic conditions at a flow rate of 1 ml/
min with monitoring at 254 nm. The mobile phase contained
40 mM NaH2PO4, 6 mM heptanesulfonic acid sodium salt
(Sigma), and 15% methanol, pH 4. AdoHcy and AdoMet eluted
as single peaks with retention times of 7 and 13 min respectively.
The concentrations of AdoMet and AdoHcy in the samples were
determined using calibration curves generated for each compound
and normalized to the cell count in the suspension (i.e., expressed
as mmoles/l cells). Based on an estimated cell diameter of 25–
30 mm, the calculated value for the cell volume is 1?10
211 l.
To measure methionine concentration, the supernatant ob-
tained after protein precipitation was derivatized with 2,4-
dinitrofluorobenzene [30] and analyzed by HPLC using a 5 mm
Diaspher-110 ODS column, 25064 mm (BioChemMack, Russia)
under isocratic conditions at a flow rate of 1 ml/min with
monitoring at 355 nm. The mobile phase contained 45%
acetonitrile in 1% acetic acid in water. The retention time of
derivatized methionine was 12 min. The concentration of
methionine in the samples was determined using a calibration
curve and expressed as mmoles/l of suspension. The change in
methionine concentration, due to intracellular metabolism in cell
suspension over time was approximated by linear kinetics. The
slope of the corresponding line and its deviation were determined
using the Microcal Origin 6.0 software (Microcal Software, Inc.).
To determine the rate of methionine consumption in hepatocytes,
the slope was normalized to the total cell volume in suspension as
described above.
As it was mentioned above, methionine transport in hepatocytes
is passive, reversible and very fast over a wide range of [Met] (from
18 mM to 10 mM) and equilibrium between extracellular and
intracellular methionine concentrations can be established within
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methionine concentrations are similar in hepatocyte suspensions
and in normal liver [30,31,33]. Thus, under our experimental
conditions the total methionine concentration in cell suspension
represents both medium and intracellular methionine concentra-
tion, and the rate of decrease in methionine concentration in
suspension represents the rate of metabolic methionine consump-
tion (catabolism) by the cells.
Accession Numbers
The accession numbers of enzymes used in the model are
defined in Text S1.
Supporting Information
Figure S1 Kinetic scheme for reaction mechanism of MATIII
containing two identical-subunits each with a catalytic and an
allosteric site. The thick and thin arrows indicate reversible and
irreversible steps, respectively. S, P, and M denote substrate,
product, and effector and E, E-S, and E-2S denote free and
different substrate-bound forms of enzyme, respectively. Param-
eter b determines cooperative effect of substrate binding to
enzyme. Asterisks indicate enzyme with effector bound to one or
two subunits. KS1,K S2,K S3 denote dissociation constants of
enzyme-substrate complexes. kf1,k f2,k f3 denote rate constants of
product formation. KM denotes dissociation constant for effector
in allosteric site. Coefficients 2 and 0.5 are statistical factors
reflecting dimeric structure of the enzyme (see Hofmeyr JH,
Cornish-Bowden A (1997) The reversible Hill equation: how to
incorporate cooperative enzymes into metabolic models. Comput
Appl Biosci 13: 377–385).
Found at: doi:10.1371/journal.pcbi.1000076.s001 (0.87 MB TIF)
Figure S2 Simulation of experimental MATIII kinetic data
using the equation for the MATIIIreaction rate described in this
study. Symbols show experimental data obtained in (Sullivan DM,
Hoffman JL (1983) Fractionation and kinetic properties of rat liver
and kidney methionine adenosyltransferase isozymes. Biochemis-
try 22: 1636–1641) in vitro with purified rat MATIII at [AdoMet]
of 0 mM (square), 50 mM (triangle), 200 mM (circle), and 500 mM
(inverted triangle). The corresponding curves shown by solid, dash,
dot, and dash dot lines were calculated using Equation S18 and
the following parameter values: b~0:1, KMATIII
S,Met ~1200 mM,
KMATIII
A,AdoMet~95 mM, KMATIII
i,AdoMet~400 mM.
Found at: doi:10.1371/journal.pcbi.1000076.s002 (0.14 MB TIF)
Figure S3 The predicted dependence of steady-state AdoMet
production (dashed line) and consumption (solid line) rates on
[AdoMet], at different [Met] of (A) 50 mM, (B) 80 mM, and (C)
100 mM. Points 1 and 3 correspond to stable steady states, while
point 2 corresponds to unstable steady state. Curves were
calculated at MATI activity of 1 mmol/h?l cells. All other
parameter values are given in Tables S1 and S2. The insets show
intersections of the curves in greater detail.
Found at: doi:10.1371/journal.pcbi.1000076.s003 (0.26 MB TIF)
Figure S4 The dependence of (A) steady-state [AdoMet] and (B)
transsulfuration/transmethylation ratio on [Met] in the model.
Solid and dashed lines show points corresponding to stable and
unstable steady states respectively. Circles (points 1 and 2) indicate
steady states corresponding to lower and upper bounds of [Met],
limiting the area of existence of multiple steady states. Arrows
indicate movement of the steady-state point in case of increase in
[Met] for point 1 or decrease in [Met] for point 2. Curves were
calculated at MATI activity of 1 mmol/h?l cells. All other
parameter values are given in Tables S1 and S2.
Found at: doi:10.1371/journal.pcbi.1000076.s004 (0.25 MB TIF)
Figure S5 The dependence of steady-state [AdoMet] on [Met]
in the model, calculated at different MATI activity. MATI activity
in mmol/h?l cells is indicated above the corresponding curves.
The solid line represents the curve shown in Figure 3A. All
parameter values except MATI activity used for the calculations
are given in Tables S1 and S2.
Found at: doi:10.1371/journal.pcbi.1000076.s005 (0.19 MB TIF)
Table S1 Values of enzyme kinetic parameters in the model.
Found at: doi:10.1371/journal.pcbi.1000076.s006 (0.29 MB
DOC)
Table S2 Concentrations of metabolites assumed to be constant
in the model.
Found at: doi:10.1371/journal.pcbi.1000076.s007 (0.08 MB
DOC)
Table S3 Normal physiological steady-state values of variables
in the model.
Found at: doi:10.1371/journal.pcbi.1000076.s008 (0.09 MB
DOC)
Text S1 Mathematical model description.
Found at: doi:10.1371/journal.pcbi.1000076.s009 (0.21 MB
DOC)
Text S2 Description of the equation for the MATIII reaction
rate.
Found at: doi:10.1371/journal.pcbi.1000076.s010 (0.12 MB
DOC)
Text S3 Mechanism of bistability in the model.
Found at: doi:10.1371/journal.pcbi.1000076.s011 (0.03 MB
DOC)
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